Splenic siderotic nodules in patients with liver cirrhosis

Ouyang,Huang‑Qing; Gong,Zuo‑Jiong; Zha,Yun‑Fei; Liu,Chang‑Sheng; Yang,Zhao‑Hui

doi:10.3892/etm.2013.1135

Splenic siderotic nodules in patients with liver cirrhosis

Authors:
- Huang‑Qing Ouyang
- Zuo‑Jiong Gong
- Yun‑Fei Zha
- Chang‑Sheng Liu
- Zhao‑Hui Yang
View Affiliations

Affiliations: Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: May 31, 2013 https://doi.org/10.3892/etm.2013.1135
Pages: 445-450

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the interrelation between splenic siderotic nodules, hypersplenism and liver function in patients with liver cirrhosis. The splenic enhanced susceptibility‑weighted angiography (ESWAN) and conventional magnetic resonance images of 33 patients with liver cirrhosis were retrospectively studied and the ESWAN images were graded. The distribution and prevalence of the image grades for patients with and without hypersplenism were evaluated. In addition, the splenic volume and the distribution of Child‑Pugh and albumin scores were compared between patients with and without siderotic nodules, and the correlation between splenic volume and the ESWAN image grades were evaluated in the patients with siderotic nodules. The ESWAN images revealed splenic siderotic nodules in 24 patients. The distribution and prevalence of the ESWAN image grades were demonstrated to be significantly different (P<0.001) between patients with and without hypersplenism. Furthermore, significant differences were observed between patients with and without siderotic nodules with regard to splenic volume and the distribution of Child‑Pugh and serum albumin scores (P<0.001). No significant correlation was demonstrated between splenic volume and the ESWAN image grades (P>0.05). In conclusion, a higher prevalence of splenic siderotic nodules (72.7%) was observed using the ESWAN sequence, in comparison with results from previous studies, obtained using the T1‑spoiled gradient echo sequence. The presence of splenic siderotic nodules was consistent with the occurrence of hypersplenism and was interrelated with reserved liver function.

View Figures

View References

1.	Yilmaz S, Yekeler E and Rozanes I: Education and imaging. Hepatobiliary and pancreatic: Gamna-Gandy bodies of the spleen. J Gastroenterol Hepatol. 22:7582007. View Article : Google Scholar : PubMed/NCBI
2.	Piccin A, Rizkalla H, Smith O, McMahon C, Furlan C, Murphy C, et al: Composition and significance of splenic Gamna-Gandy bodies in sickle cell anemia. Hum Pathol. 43:1028–1036. 2012. View Article : Google Scholar : PubMed/NCBI
3.	Minami M, Itai Y, Ohtomo K, Ohnishi S, Niki T, Kokubo T, et al: Siderotic nodules in the spleen: MR imaging of portal hypertension. Radiology. 172:681–684. 1989. View Article : Google Scholar : PubMed/NCBI
4.	Sagoh T, Itoh K, Togashi K, Shibata T, Nishimura K, Minami S, et al: Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology. 172:685–687. 1989. View Article : Google Scholar : PubMed/NCBI
5.	Selçuk D, Demirel K, Kantarci F, Mihmanli I and Oğüt G: Gamna-Gandy bodies: a sign of portal hypertension. Turk J Gastroenterol. 16:150–152. 2005.
6.	Dobritz M, Nömayr A, Bautz W and Fellner FA: Gamna-Gandy bodies of the spleen detected with MR imaging: a case report. Magn Reson Imaging. 19:1249–1251. 2001. View Article : Google Scholar : PubMed/NCBI
7.	Unsal NH, Erden A and Erden I: Evaluation of the splenic vein diameter and longitudinal size of the spleen in patients with Gamna-Gandy bodies. Diagn Interv Radiol. 12:125–128. 2006.PubMed/NCBI
8.	Haacke EM, Mittal S, Wu Z, Neelavalli J and Cheng YC: Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol. 30:19–30. 2009. View Article : Google Scholar
9.	Mittal S, Wu Z, Neelavalli J and Haacke EM: Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol. 30:232–252. 2009. View Article : Google Scholar : PubMed/NCBI
10.	Gao T, Wang Y and Zhang Z: Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis. Neurol Res. 30:272–276. 2008. View Article : Google Scholar : PubMed/NCBI
11.	Rauscher A, Sedlacik J, Barth M, Mentzel HJ and Reichenbach JR: Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol. 26:736–742. 2005.PubMed/NCBI
12.	Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, et al: Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging. 24:41–51. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Mahmood NS, Kadavigere R, Avinash KR and Rao VR: Magnetic resonance imaging in acute cervical spinal cord injury: a correlative study on spinal cord changes and 1 month motor recovery. Spinal Cord. 46:791–797. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Yang Q, Liu J, Barnes SR, Wu Z, Li K, Neelavalli J, et al: Imaging the vessel wall in major peripheral arteries using susceptibility-weighted imaging. J Magn Reson Imaging. 30:357–365. 2009. View Article : Google Scholar : PubMed/NCBI
15.	Dai Y, Zeng M, Li R, Rao S, Chen C, DelProposto Z, et al: Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. J Magn Reson Imaging. 34:318–325. 2011. View Article : Google Scholar : PubMed/NCBI
16.	Kim MJ, Mitchell DG, Ito K, Hann HW, Park YN and Kim PN: Hepatic iron deposition on MR imaging in patients with chronic liver disease: correlation with serial serum ferritin concentration. Abdom Imaging. 26:149–156. 2001. View Article : Google Scholar : PubMed/NCBI
17.	Vitellas KM, Tzalonikou MT, Bennett WF, Vaswani KK and Bova JG: Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging. Abdom Imaging. 26:601–615. 2001. View Article : Google Scholar : PubMed/NCBI
18.	Laurent O, Lubrano J, de Beauregard M, Aubry S, Kastler B and Delabrousse É: Gamna-Gandy bodies in cirrhosis: a meaningless finding? J Radiol. 92:909–914. 2011.(In French).
19.	Liangpunsakul S, Ulmer BJ and Chalasani N: Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci. 326:111–116. 2003. View Article : Google Scholar : PubMed/NCBI
20.	Peck-Radosavljevic M: Hypersplenism. Eur J Gastroenterol Hepatol. 13:317–323. 2001.
21.	Peck-Radosavljevic M: Thrombocytopenia in liver disease. Can J Gastroenterol. 14(Suppl D): 60D–66D. 2000.
22.	Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T and Akarca US: Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 52:1535–1539. 2007. View Article : Google Scholar : PubMed/NCBI
23.	Zucker ML, Hagedorn CH, Murphy CA, Stanley SS, Reid KJ and Skikne BS: Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction. Int J Lab Hematol. 34:525–532. 2012. View Article : Google Scholar : PubMed/NCBI